|
1
|
Trivers KF, Sabatino SA and Stewart SL:
Trends in esophageal cancer incidence by histology, United States,
1998–2003. Int J Cancer. 123:1422–1428. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008. GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shibata-Kobayashi S, Yamashita H, Okuma K,
Shiraishi K, Igaki H, Ohtomo K and Nakagawa K: Correlation among 16
biological factors [p53, p21(waf1), MIB-1 (Ki-67), p16(INK4A),
cyclin D1, E-cadherin, Bcl-2, TNF-α, NF-κB, TGF-β, MMP-7, COX-2,
EGFR, HER2/neu, ER, and HIF-1α] and clinical outcomes following
curative chemoradiation therapy in 10 patients with esophageal
squamous cell carcinoma. Oncol Lett. 5:903–910. 2013.PubMed/NCBI
|
|
5
|
Wang S, Liu H, Wang Z and Chen HX: Effects
of 5-azacytidine on RUNX3 gene expression and the biological
behavior of esophageal carcinoma cells. Mol Med Rep. 9:1259–1265.
2014.PubMed/NCBI
|
|
6
|
Rasool S, Khan T, Qazi F and Ganai BA:
ECRG1 and its relationship with esophageal cancer: A brief review.
Onkologie. 36:213–216. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
D'Annoville T, D'Journo XB, Loundou A,
Trousse D, Dahan L, Doddoli C, Seitz JF and Thomas PA: Prognostic
impact of the extracapsular lymph node involvement on disease-free
survival according to the 7th edition of American Joint Committee
on Cancer Staging System. Eur J Cardiothorac Surg. 44:e207–211.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kamangar F, Chow WH, Abnet CC and Dawsey
SM: Environmental causes of esophageal cancer. Gastroenterol Clin
North Am. 38:27–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lieber MR, Gu J, Lu H, Shimazaki N and
Tsai AG: Nonhomologous DNA end joining (NHEJ) and chromosomal
translocations in humans. Subcell Biochem. 50:279–296. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fink LS, Lerner CA, Torres PF and Sell C:
Ku80 facilitates chromatin binding of the telomere binding protein,
TRF2. Cell Cycle. 9:3798–3806. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang QS, Gu JL, Du LQ, Jia LL, Qin LL,
Wang Y and Fan FY: ShRNA-mediated Ku80 gene silencing inhibits cell
proliferation and sensitizes to gamma-radiation and mitomycin
C-induced apoptosis in esophageal squamous cell carcinoma lines. J
Radiat Res. 49:399–407. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Groselj B, Kerr M and Kiltie AE:
Radiosensitisation of bladder cancer cells by panobinostat is
modulated by Ku80 expression. Radiother Oncol. 108:429–433. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kruer TL, Cummins TD, Powell DW and
Wittliff JL: Characterization of estrogen response element binding
proteins as biomarkers of breast cancer behavior. Clin Biochem.
46:1739–1746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tonotsuka N, Hosoi Y, Miyazaki S, Miyata
G, Sugawara K, Mori T, Ouchi N, Satomi S, Matsumoto Y, Nakagawa K,
et al: Heterogeneous expression of DNA-dependent protein kinase in
esophageal cancer and normal epithelium. Int J Mol Med. 18:441–447.
2006.PubMed/NCBI
|
|
15
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours. 7th. Wiley-Blackwell;
Oxford, UK: 2009
|
|
16
|
Hamilton SR and Aaltonen LA: Pathology and
genetics of tumours of the digestive systemWorld Health
Organization Classification of Tumours. Kleihues P and Sobin LH:
IARC Press; Lyon, France: pp. 237–240. 2000
|
|
17
|
Koike M, Shiomi T and Koike A:
Dimerization and nuclear localization of ku proteins. J Biol Chem.
276:11167–11173. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song Y, Wang Z, Liu X, Jiang W and Shi M:
CCR7 and VEGF-C: Molecular indicator of lymphatic metastatic
recurrence in pN0 esophageal squamous cell carcinoma after
Ivor-Lewis esophagectomy? Ann Surg Oncol. 19:3606–3612. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Finnie NJ, Gottlieb TM, Blunt T, Jeggo PA
and Jackson SP: DNA-dependent protein kinase activity is absent in
xrs-6 cells: Implications for site-specific recombination and DNA
double-strand break repair. Proc Natl Acad Sci USA. 92:320–324.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shrivastav M, Miller CA, De Haro LP,
Durant ST, Chen BP, Chen DJ and Nickoloff JA: DNA-PKcs and ATM
co-regulate DNA double-strand break repair. DNA Repair (Amst).
8:920–929. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gullo C, Au M, Feng G and Teoh G: The
biology of Ku and its potential oncogenic role in cancer. Biochim
Biophys Acta. 1765:223–234. 2006.PubMed/NCBI
|
|
22
|
Liu ES and Lee AS: Common sets of nuclear
factors binding to the conserved promoter sequence motif of two
coordinately regulated ER protein genes, GRP78 and GRP94. Nucleic
Acids Res. 19:5425–5431. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lim JW, Kim H and Kim KH: Expression of
Ku70 and Ku80 mediated by NF-kappa B and cyclooxygenase-2 is
related to proliferation of human gastric cancer cells. J Biol
Chem. 277:46093–46100. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hosoi Y, Watanabe T, Nakagawa K, Matsumoto
Y, Enomoto A, Morita A, Nagawa H and Suzuki N: Up-regulation of
DNA-dependent protein kinase activity and Sp1 in colorectal cancer.
Int J Oncol. 25:461–468. 2004.PubMed/NCBI
|
|
25
|
Ma Q, Li P, Xu M, Yin J, Su Z, Li W and
Zhang J: Ku80 is highly expressed in lung adenocarcinoma and
promotes cisplatin resistance. J Exp Clin Cancer Res. 31:992012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grabsch H, Dattani M, Barker L, Maughan N,
Maude K, Hansen O, Gabbert HE, Quirke P and Mueller W: Expression
of DNA double-strand break repair proteins ATM and BRCA1 predicts
survival in colorectal cancer. Clin Cancer Res. 12:1494–1500. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alshareeda AT, Negm OH, Albarakati N,
Green AR, Nolan C, Sultana R, Madhusudan S, Benhasouna A, Tighe P,
Ellis IO and Rakha EA: Clinicopathological significance of
KU70/KU80, a key DNA damage repair protein in breast cancer. Breast
Cancer Res Treat. 139:301–310. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leifler K Söderlund, Queseth S, Fornander
T and Askmalm MS: Low expression of Ku70/80, but high expression of
DNAPKcs, predict good response to radiotherapy in early breast
cancer. Int J Oncol. 37:1547–1554. 2010.PubMed/NCBI
|
